In the fast-paced world of healthcare, quick and accurate diagnostics can be the difference between life and death. However, traditional diagnostic methods can be slow, expensive, and require specialized facilities and personnel. This is where Sherlock Biosciences comes in – an engineering biology company that is revolutionizing diagnostics with its cutting-edge technology. In this startup showcase, we’ll take a closer look at Sherlock Biosciences, its mission, and how it’s changing the game in the diagnostics industry.
About Sherlock Biosciences
Sherlock Biosciences is a Cambridge-based engineering biology company that was founded in 2019. The company offers a broad range of diagnostic solutions using its proprietary engineering biology tools, including CRISPR and Synthetic Biology. By leveraging these tools, Sherlock Biosciences can create molecular diagnostics that can rapidly deliver accurate results for a vast range of needs in virtually any setting. The company’s innovative technology combines the diagnostic power of SHERLOCK with that of a second core platform technology, INSPECTRTM. Together, these technologies create diagnostic tools that are simple and easy to use in virtually any setting while providing accurate, rapid, and affordable results.
Sherlock Biosciences’ innovative technology has the potential to revolutionize diagnostics in several ways. Firstly, the company’s technology can be used to create highly accurate diagnostics that are more affordable than traditional methods. This is because the company’s diagnostics can be used in low-resource settings and don’t require specialized personnel to operate. Additionally, Sherlock Biosciences’ technology allows for the creation of highly specific diagnostics that can detect a wide range of diseases and conditions. This specificity can help healthcare professionals make more accurate diagnoses and prescribe more targeted treatments.
Sherlock Biosciences’ technology has a wide range of applications. The company’s diagnostics can be used to detect infectious diseases, genetic disorders, and even cancer. The company’s technology can also be used for environmental testing, such as detecting the presence of harmful chemicals in water or soil. With such a broad range of applications, Sherlock Biosciences’ technology has the potential to make a significant impact on many different areas of healthcare and beyond.
Partnerships and Collaborations
Sherlock Biosciences has formed several partnerships and collaborations to further develop its technology and bring its diagnostics to market. In 2020, the company announced a collaboration with Binx Health, a digital health company that focuses on providing rapid, point-of-care diagnostic testing. The collaboration aims to develop a rapid, single-use, and disposable diagnostic test for COVID-19 that can be used in low-resource settings. Additionally, Sherlock Biosciences has partnered with companies such as Ginkgo Bioworks and AstraZeneca to develop diagnostics for a range of applications.
Sherlock Biosciences is an engineering biology company that is using cutting-edge technology to revolutionize diagnostics. By combining the diagnostic power of SHERLOCK with that of INSPECTRTM, the company has created a range of diagnostics that are accurate, rapid, and affordable. With a wide range of applications, Sherlock Biosciences’ technology has the potential to make a significant impact on many different areas of healthcare and beyond. With partnerships and collaborations, the company is well-positioned to bring its technology to market and change the game in the diagnostics industry.